Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metolazone vs Chlorothiazide for Diuretic Resistance in Heart Failure
NCT03574857Phase 4Terminated
- Sponsor
- University of Virginia
- Start
- Jun 2018
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in acute decompensated heart failure (ADHF) comparing Metolazone with Chlorothiazide (2 arms). Primary endpoint: Net urine output at 24 hours. Started Jun 2018; status: terminated.
02
Drugs
metolazonechlorothiazide
03
Conditions
acute decompensated heart failure (ADHF)
Beyond the preview
Go deeper on NCT03574857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03574857.